Search

Search Results

• Practice parameters for sublingual immunotherapy

  C. Ortolani, F. Agostinis, S. Amoroso, R. Ariano, A. Barbato, M. Bassi, G. Cadario, P. Campi, F. Cardinale, G. Ciprandi, R. D’Anneo, M. Di Gioacchino, V. Di Rienzo, A. Fiocchi, M. Galimberti, E. Galli, M. Giovannini, C. Incorvaia, S. La Grutta, C. Lombardi, F. Marcucci, G. Marseglia, M. Minelli, A. Musarra, E. Nettis, E. Novembre, G. Pajno, G. Patriarca, F. Pezzuto, P. Piras, S. Pucci, A. Romano, C. Romano, O. Quercia, G. Scala, D. Schiavino, G. Sforza, M. Tosca, S. Tripodi, F. Frati

  2016-02-15

  Published: February 15, 2016

  978

  PDF: 584

• Dose dependence of efficacy but not of safety in sublingual immunotherapy

  F. Frati, C. Incorvaia, F. Marcucci, L. Sensi, G. Di Cara, P. Puccinelli, S. Dal Bo

  2016-02-15

  Published: February 15, 2016

  735

  PDF: 426

• Allergen-specific immunotherapy: an update on immunological mechanisms of action

  G. Ciprandi, G.L. Marseglia, M.A. Tosca

  2016-02-15

  Published: February 15, 2016

  740

  PDF: 516

• Dose dependence of efficacy and safety of subcutaneous immunotherapy

  C. Incorvaia, F. Frati, P. Puccinelli, G.G. Riario-Sforza, S. Dal Bo

  2016-02-15

  Published: February 15, 2016

  943

  PDF: 422

• Survival among patients with lung cancer managed at a tertiary care center in North India

  Rahul Kumar, Dipti Gothi, Shweta Anand, Shazia Khan, Nipun Malhotra

  2024-07-26

  Published: July 26, 2024

  315

  PDF_EARLY VIEW: 194
• 

  Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer

  Elena Bargagli, Viola Bonti, Alessandra Bindi, Vieri Scotti, Massimo Pistolesi, Luca Voltolini, Katia Ferrari

  2018-06-21

  Published: June 21, 2018

  3166

  PDF: 961
• 

  Pulmonary adverse events due to immune checkpoint inhibitors: A literature review

  Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki

  2021-10-11

  Published: October 11, 2021

  1799

  PDF: 880

• The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature

  Eleni D. Eleftheriadou, Maria Saroglou, Nikolaos Syrigos, Ellias Kotteas, Marousa Kouvela

  2024-07-26

  Published: July 26, 2024

  289

  PDF_EARLY VIEW: 121
• 

  Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report

  Paola Maria Medusa , Marina Gilli, Luca Notizia, Raffaella Pagliaro, Nicola Carro, Alessandro Moriello, Vito D'Agnano, Andrea Bianco, Fabio Perrotta, Fabiana Vitiello

  2022-11-25

  Published: November 25, 2022

  1183

  PDF: 301

• Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review

  G. Caramori, D. Artioli, G. Ferrara, R. Cazzuffi, C. Pasquini, M. Libanore, V. Guardigni, I. Guzzinati, M. Contoli, R. Rossi, R. Rinaldi, C. Contini, A. Papi

  2015-11-26

  Published: November 26, 2015

  1946

  PDF: 947
• 

  Interstitial nephritis secondary to treatment with pembrolizumab, a rare complication in two patients with lung adenocarcinoma

  Diana Alexandra Gonçalves Pimenta, Renata Carvalho, Raquel Pereira, Rui Rolo, Lurdes Ferreira

  2022-07-28

  Published: July 28, 2022

  940

  PDF: 361